Literature DB >> 7681680

Metallothionein induction in freshly isolated rat hepatocytes.

P Coyle1, J C Philcox, A M Rofe.   

Abstract

The control of metallothionein (MT) synthesis was investigated in freshly prepared rat hepatocytes in experiments of short-term duration. Viability and metabolic function were maintained in incubations of 6-h duration. MT synthesis was measurable in hepatocytes from fed rats at Zn concentrations down to 1 microM. Zn and dexamethasone induced concentration-dependent increases in the synthesis of MT with maximal increases above the 5-h control of 3.2- and 2.5-fold, respectively. Zn induction of MT was first measurable at 2 h and was inhibited by actinomycin C. Although initial (0 h) MT concentrations in hepatocytes from fasted rats were double those from fed rats, after 6-h incubation in the presence of 50 microM Zn, the fasted rat hepatocytes showed only half the MT concentrations of the fed rat hepatocytes. Glucagon and interleukin-6 (IL-6) were less effective inducers and increased MT synthesis by 28 and 17%, respectively. IL-6 (100 U/mL) was found to have an additive effect on MT synthesis above that of Zn alone (1-50 microM) or Zn plus dexamethasone (1 microM). A supernatant from LPS-stimulated macrophages increased MT synthesis by 40%. The basal MT synthesis was not increased by either tumor necrosis factor-alpha (TNF-alpha) or interleukin-1 (IL-1). All incubations were carried out in the presence of RPMI 1640 medium with Hepes (20 mM), bicarbonate (24 mM), and fatty acid-free albumin (FAFA; 0.5% w/v). MT synthesis was also seen using Krebs bicarbonate buffer with glucose (10 mM), Hepes (20 mM), and FAFA (0.5% w/v), and although the level of MT synthesis was less than in RPMI, the increases in concentrations of MT at 5 h were 225, 139, 36 and 20% for Zn, dexamethasone, glucagon, and control, respectively. It is concluded that MT synthesis occurs in freshly prepared hepatocytes and that these cells are responsive to some of the established inducers of MT. This system enables the study of MT synthesis in individual rats in various metabolic and pathological states.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681680     DOI: 10.1007/BF02783778

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  26 in total

Review 1.  Metallothionein and the trace minerals.

Authors:  I Bremner; J H Beattie
Journal:  Annu Rev Nutr       Date:  1990       Impact factor: 11.848

2.  Maintenance of zinc-dependent hepatic functions in rat hepatocytes cultured in medium without added zinc.

Authors:  J J Schroeder; R J Cousins
Journal:  J Nutr       Date:  1991-06       Impact factor: 4.798

Review 3.  Cytokines in disease.

Authors:  J T Whicher; S W Evans
Journal:  Clin Chem       Date:  1990-07       Impact factor: 8.327

4.  Interleukin-6. The major regulator of acute-phase protein synthesis in man and rat.

Authors:  J V Castell; T Andus; D Kunz; P C Heinrich
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

5.  Effect of gold salt treatment on the receptor binding activity of monocytes and macrophages isolated from rats with adjuvant arthritis.

Authors:  D R Haynes; I R Garrett; B Vernon-Roberts
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

Review 6.  Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin.

Authors:  R J Cousins
Journal:  Physiol Rev       Date:  1985-04       Impact factor: 37.312

7.  Changes in plasma zinc, copper, iron, and hepatic metallothionein in adjuvant-induced arthritis treated with cyclosporin.

Authors:  A M Rofe; J C Philcox; D R Haynes; M W Whitehouse; P Coyle
Journal:  Biol Trace Elem Res       Date:  1992-09       Impact factor: 3.738

8.  Induction of metallothionein by steroids in rat primary hepatocyte cultures.

Authors:  W M Bracken; C D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  1987-03-15       Impact factor: 4.219

9.  The protective effect of metallothionein on the toxicity of various metals in rat primary hepatocyte culture.

Authors:  J Liu; W C Kershaw; C D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  1991-01       Impact factor: 4.219

10.  Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures.

Authors:  J J Schroeder; R J Cousins
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

View more
  6 in total

1.  Hepatic zinc in metallothionein-null mice following zinc challenge: in vivo and in vitro studies.

Authors:  P Coyle; J C Philcox; A M Rofe
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

2.  Regulation of bovine acute phase responses by recombinant interleukin-1 beta.

Authors:  D L Godson; M E Baca-Estrada; A G Van Kessel; H P Hughes; M A Morsy; J Van Donkersgoed; R J Harland; D E Shuster; M J Daley; L A Babiuk
Journal:  Can J Vet Res       Date:  1995-10       Impact factor: 1.310

3.  Wasting in adjuvant-induced arthritis and its relationship to plasma zinc, copper and liver metallothionein.

Authors:  A M Rofe; J C Philcox; D R Haynes; P Coyle
Journal:  Agents Actions       Date:  1994-08

4.  Metallothionein induction in cultured rat hepatocytes by arthritic rat serum, activated macrophages, interleukin-6, interleukin-11 and leukaemia inhibitory factor.

Authors:  P Coyle; J C Philcox; A M Rofe
Journal:  Inflamm Res       Date:  1995-11       Impact factor: 4.575

5.  Measurement of zinc in hepatocytes by using a fluorescent probe, zinquin: relationship to metallothionein and intracellular zinc.

Authors:  P Coyle; P D Zalewski; J C Philcox; I J Forbes; A D Ward; S F Lincoln; I Mahadevan; A M Rofe
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

6.  Endotoxin-induced inflammation does not cause hepatic zinc accumulation in mice lacking metallothionein gene expression.

Authors:  J C Philcox; P Coyle; A Michalska; K H Choo; A M Rofe
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.